This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation
Cellular and Molecular Life Sciences Open Access 12 September 2022
-
Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values
BMC Pulmonary Medicine Open Access 29 June 2022
-
Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model
Cellular and Molecular Life Sciences Open Access 13 May 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Murphy, P.M. et al. International Union of Pharmacology. XXII. Pharmacol. Rev. 52, 145–176 (2000).
Mantovani, A., Bonecchi, R. & Locati, M. Nat. Rev. Immunol. 6, 907–918 (2006).
Bachelerie, F. et al. International Union of Pharmacology. Pharmacol. Rev. 66, 1–79 (2013).
Borroni, E.M. et al. Sci. Signal. 6, ra30 (2013).
Rajagopal, S. et al. Proc. Natl. Acad. Sci. USA 107, 628–632 (2010).
Watts, A.O. et al. J. Biol. Chem. 288, 7169–7181 (2013).
Donà, E. et al. Nature 503, 285–289 (2013).
Pruenster, M. et al. Nat. Immunol. 10, 101–108 (2009).
Fra, A.M. et al. J. Immunol. 170, 2279–2282 (2003).
Martinez de la Torre, Y. et al. Proc. Natl. Acad. Sci. USA 104, 2319–2324 (2007).
Nibbs, R.J. et al. J. Clin. Invest. 117, 1884–1892 (2007).
Jamieson, T. et al. Nat. Immunol. 6, 403–411 (2005).
Boldajipour, B. et al. Cell 132, 463–473 (2008).
Bunting, M.D. et al. Blood 121, 118–128 (2013).
Del Prete, A., Bonecchi, R., Vecchi, A., Mantovani, A. & Sozzani, S. Eur. J. Immunol. 43, 1418–1422 (2013).
Nibbs, R.J.B. & Graham, G.J. Nat. Rev. Immunol. 13, 815–829 (2013).
Acknowledgements
Authors are listed in alphabetical order. Supported by Investissements d'Avenir (supporting the Laboratory of Excellence in Research on Medication and Innovative Therapeutics of which F.B. is a member), INSERM (F.B.), ERA-Net for Research Programmes on Rare Diseases (E-Rare-013 to F.B.), the Italian Association for Cancer Research (A.M., M.L. and S.S.), European Commission (A.M. and M.L.), the Italian Ministry of Education, Universities and Research (A.M., M.L. and S.S.), the Italian Ministry of Health (A.M. and M.L.), the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (P.M.M.), the Medical Research Council (G.J.G. and R.N.; G0802838 to A.R.), the Helmut Horten Foundation (M.T.) and the Swiss National Science Foundation (M.T.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bachelerie, F., Graham, G., Locati, M. et al. New nomenclature for atypical chemokine receptors. Nat Immunol 15, 207–208 (2014). https://doi.org/10.1038/ni.2812
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2812
This article is cited by
-
Roles of NOLC1 in cancers and viral infection
Journal of Cancer Research and Clinical Oncology (2023)
-
Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values
BMC Pulmonary Medicine (2022)
-
Analysis of CCR2 splice variant expression patterns and functional properties
Cell & Bioscience (2022)
-
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models
Nature Communications (2022)
-
Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting β-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis
Acta Pharmacologica Sinica (2022)